Latest News about BNTX
Recent news which mentions BNTX
From Benzinga
Why BioNTech SE Was Surging Today
April 25, 2022
From Motley Fool
Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters
April 25, 2022
From Benzinga
If You Invested $1,000 In BioNTech Stock At Its Pandemic Low, Here's How Much You'd Have Now
April 22, 2022
From Benzinga
From Motley Fool
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
April 22, 2022
From InvestorPlace
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
April 22, 2022
From Benzinga
Pfizer: What Comes After the Covid-19 Fire?
April 21, 2022
From InvestorPlace
2 Monster Stocks to Buy Without Any Hesitation
April 21, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
From InvestorPlace
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
From Motley Fool
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
Moderna is developing a COVID-19 booster that protects against omicron and the original virus
April 19, 2022
From MarketWatch
From Benzinga
Why Ocugen Stock Tumbled by Nearly 6% Today
April 18, 2022
From Motley Fool
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
April 18, 2022
From Motley Fool
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
April 18, 2022
From Benzinga
From Benzinga
From Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
Novavax: The Party’s Over
April 15, 2022
From InvestorPlace
New York State’s recent COVID case surge caused by two new versions of omicron that are even more infectious than BA.2
April 14, 2022
From MarketWatch
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Aged 5-11 Years
April 14, 2022
From Benzinga
From Motley Fool
From Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.